Amount of drug development to model-based AAPS workshop

WHY ‘: The purpose of this workshop is to provide basic education and practical training on technical and theoretical pre-clinical pharmacokinetic / pharmacodynamic modeling. Concepts and principles of PK / PD modeling and simulation will be introduced, the case studies will be discussed and strategies to overcome challenges, such as grain structure, interdisciplinary communication, and decision-making infrastructure will also be discussed.WHO: The American Association of Pharmaceutical Scientists is a professional, scientific society of nearly 12,000 members working in industry, academia, government and other research institutions. Founded in 1986, AAPS provides a dynamic forum for international exchange of knowledge among scientists to enhance their contribution to public health. AAPS offers timely scientific programs, ongoing education, information resources, networking opportunities and professional development.

‘The results of this study means that not only doctors have a more powerful tool to help treat breast cancer, but that PEM is legitimate and better alternative for 16 percent of women who can not tolerate MR due metallic implants, body habitus, or gadolinium reaction, ‘said Wendie Berg, MD, Ph.D. Berg has recently published an article in the January 2010 issue of the journal Radiology examining the reasons for women at high risk who have been recommended for a screening test for cancer MR refused to take the exam.

Training event will take place before 2009 AAPS Annual Meeting and Exhibition.

Amount of drug development to model-based AAPS workshop